BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25600204)

  • 1. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
    Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
    Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
    Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
    Halladay JS; Wong S; Khojasteh SC; Grepper S
    J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450.
    Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H
    Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
    Bachmann F; Duthaler U; Meyer Zu Schwabedissen HE; Puchkov M; Huwyler J; Haschke M; Krähenbühl S
    Clin Pharmacol Ther; 2021 Jun; 109(6):1505-1516. PubMed ID: 33336382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
    Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
    Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction.
    Meneses-Lorente G; Pattison C; Guyomard C; Chesné C; Heavens R; Watt AP; Sohal B
    Drug Metab Dispos; 2007 Feb; 35(2):215-20. PubMed ID: 17093007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-endpoint evaluation of cytochrome P450 1A2, 2B6 and 3A4 induction response in human hepatocyte cultures after treatment with β-naphthoflavone, phenobarbital and rifampicin.
    Zhang JG; Ho T; Callendrello AL; Crespi CL; Stresser DM
    Drug Metab Lett; 2010 Dec; 4(4):185-94. PubMed ID: 20583967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.
    Sugiyama I; Murayama N; Kuroki A; Kota J; Iwano S; Yamazaki H; Hirota T
    Xenobiotica; 2016 Sep; 46(9):765-74. PubMed ID: 26711482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
    Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
    Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes.
    Roymans D; Van Looveren C; Leone A; Parker JB; McMillian M; Johnson MD; Koganti A; Gilissen R; Silber P; Mannens G; Meuldermans W
    Biochem Pharmacol; 2004 Feb; 67(3):427-37. PubMed ID: 15037195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of albumin and induction of CYP1A2 and CYP3A4 in novel three-dimensional culture system for human hepatocytes using micro-space plate.
    Nishimura M; Hagi M; Ejiri Y; Kishimoto S; Horie T; Narimatsu S; Naito S
    Drug Metab Pharmacokinet; 2010; 25(3):236-42. PubMed ID: 20610882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment-free High-throughput Liquid Chromatography-Multiple-Reaction Monitoring Quantification of Cytochrome P450 Proteins in Plated Human Hepatocytes Direct from 96-Well Plates Enables Routine Protein Induction Measurements.
    Savaryn JP; Liu N; Sun J; Ma J; Stresser DM; Jenkins G
    Drug Metab Dispos; 2020 Jul; 48(7):594-602. PubMed ID: 32350061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of In Silico Prediction Models for CYP3A4 and CYP2B6 Induction in Human Hepatocytes by Multiple Regression Analysis Using Azole Compounds.
    Nagai M; Konno Y; Satsukawa M; Yamashita S; Yoshinari K
    Drug Metab Dispos; 2016 Aug; 44(8):1390-8. PubMed ID: 27208383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents.
    Uehara S; Uno Y; Suzuki T; Inoue T; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Lett; 2017; 10(4):244-253. PubMed ID: 27842484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up.
    Meunier V; Bourrié M; Julian B; Marti E; Guillou F; Berger Y; Fabre G
    Xenobiotica; 2000 Jun; 30(6):589-607. PubMed ID: 10923861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.